✦ LIBER ✦

The use of recombinant human interleukin-2 in treating infectious diseases

✍ Scribed by Martin A Giedlin; Robert J Zimmerman

Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 583 KB
Volume: 4
Category: Article
ISSN: 0958-1669
DOI: 10.1016/0958-1669(93)90056-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of interleukin-13 in infectious

The role of interleukin-13 in infectious diseases and allergy

✍ Frank Brombacher 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 2 views

Potential use of human interleukin 2 as

Potential use of human interleukin 2 as an adjunct for the therapy of neoplasia, immunodeficiency and infectious disease

✍ Vincent J. Merluzzi; Kathleen Last-Barney 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 781 KB

Mini-review The role of interleukin-12 i

Mini-review The role of interleukin-12 in human infectious diseases: only a faint signature

✍ Claire Fieschi; Jean-Laurent Casanova 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

The anti-tumour efficacy of human recomb

The anti-tumour efficacy of human recombinant interleukin 2

✍ J. Bubeník; M. Indrová 📂 Article 📅 1987 🏛 Springer-Verlag 🌐 English ⚖ 339 KB

Biodistribution and pharmacokinetics of

Biodistribution and pharmacokinetics of recombinant, human 125I-interleukin-2 in mice

✍ Howard Sands; Scott E. Loveless 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 406 KB

Evaluation of production of recombinant

Evaluation of production of recombinant human interleukin-2 in fluidized bed bioreactor

✍ Ricardo B. Kratje; Roland Wagner 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

The production of recombinant human interleukin-2 in a fluidized bed bioreactor containing porous glass carriers is described. Cultivations were carried out with different medium formulations over 80 days. Maximal cell densities and product yield could be maintained even when proteinfree medium was